[Aging, disease and nerve cell death]

Y Agid1

  • 1INSERM U 289, Hôpital de La Salpêtrière, Paris.

Insights

Apoptosis, or programmed cell death, is a key process in neurodegeneration. This study found apoptosis in dopaminergic neurons of Parkinson's disease patients, suggesting it may be the final step in their degeneration.

Area of Science:

  • Neurobiology
  • Cell Biology
  • Biochemistry

Context:

  • Apoptosis, or programmed cell death, involves active cellular self-destruction.
  • Homologies exist between nematode cell death proteins (CED-3, CED-9) and vertebrate proteins (Bcl-2, ICE).
  • Initiating factors for apoptosis include genotoxicity, growth factor deprivation, and cytokines like TNF alpha.

Purpose:

  • To investigate the role of apoptosis in Parkinson's disease by examining dopaminergic neurons.
  • To differentiate biochemical abnormalities in aging, neurodegeneration, and normal nerve cell death.
  • To identify morphological and biochemical signs of apoptosis in the substantia nigra of Parkinson's patients and controls.

Summary:

  • Histopathological signs of apoptosis were observed in approximately 5% of dopaminergic neurons in Parkinson's patients.
  • TNF alpha receptors and bcl-2 gene expression were detected in these dopaminergic neurons.
  • Apoptosis may represent the terminal stage of dopaminergic neuronal degeneration in Parkinson's disease.

Impact:

  • Findings suggest distinct mechanisms for neuronal senescence, neurodegeneration, and apoptosis.
  • Understanding these mechanisms could inform neurobiologists and pharmacologists.
  • This research highlights apoptosis as a potential therapeutic target in Parkinson's disease and other neurodegenerative disorders.

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...